Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Cytotherapy. 2021 Apr 5;23(8):694–703. doi: 10.1016/j.jcyt.2021.03.001

Figure 5.

Figure 5.

T-cell epitopes elicit both CD4+ and CD8+ T-cell responses

Cytotoxic (CD8+) and helper (CD4+) T-cell response to PRAME epitope RLVELAGQSLLKDEA. Results show that this peptide activated both CD8+ and CD4+ T-cells.